Acclaro Medical Highlights UltraClear Laser-Coring for Aesthetic Skin Resurfacing

According to a recent LinkedIn post from Acclaro Medical, the company is drawing attention to its UltraClear laser platform with a focus on a feature described as Laser-Coring. The post suggests this technology enables providers to create controlled micro-channels in the skin to tailor treatments for overall appearance, texture, and visible signs of aging.

The LinkedIn content emphasizes potential benefits such as precise energy delivery, minimal bleeding, and reduced downtime compared with traditional coring approaches. It also notes that when Laser-Coring is combined with UltraClear’s resurfacing modes, the system is positioned as a customizable solution for what the company brands as “Total Skin Health.”

The post references visible results after a single treatment at 6.5 weeks post-procedure, citing a case attributed to dermatologist Joanna Chan, M.D. While no clinical data or financial metrics are provided, the focus on reduced downtime and anti-aging outcomes may indicate an effort to appeal to higher-end aesthetic practices and cash-pay patients.

For investors, this marketing-oriented update may signal continued product differentiation in the competitive aesthetic laser segment. If the claimed advantages over traditional methods translate into stronger provider adoption and pricing power, Acclaro Medical could improve recurring revenue from device placements, consumables, and service contracts over time.

The emphasis on “The Future Is Fiber” and fiber laser-enabled tissue coring also suggests a technology roadmap centered on fiber-based systems rather than legacy bulkier platforms. This positioning could be relevant as clinics look for devices that combine patient comfort, fast recovery, and operational efficiency, potentially supporting Acclaro Medical’s standing in the energy-based aesthetic device market.